SCHEMBL32688220

SCHEMBL32688220

Cc1c(-c2cccc(C(=O)N(C)c3ccccc3)c2)c(C#N)c(S)[nH]c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B2 P37059 2/20 0.39
▸ KDM1A O60341 1/20 0.38
▸ MAOA P21397 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ ACMSD Q8TDX5 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ PHGDH O43175 1/20 0.36
▸ HSD17B1 P14061 1/20 0.36
▸ PLAU P00749 1/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ PGR P06401 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32687973 0.86 ALDH1A1 (0.48) HSD17B2ACMSDKDM4ETP53GAA
SCHEMBL32687975 0.80 KDM4E (0.47) ACMSDKDM4EGAAATMKMT2A
SCHEMBL20339228 0.79 KDM4E (0.49) KDM4EGAAATMKMT2AALDH1A1
SCHEMBL32688125 0.77 ACMSD (0.37) HSD17B2ACMSDKDM4EGAAKMT2A
SCHEMBL32688402 0.71 POLB (0.49) ACMSDGAAPLAUKMT2AALDH1A1
SCHEMBL32688101 0.71 KDM4E (0.38) KDM4EGAAATMKMT2AALDH1A1
SCHEMBL32688244 0.69 ALDH1A1 (0.55) KDM4EGAAATMKMT2AALDH1A1
SCHEMBL32688430 0.69 PDE9A (0.50) ACMSDKDM4EGAAATMKMT2A
SCHEMBL18816698 0.69 HSD17B10 (0.54) KDM1AMAOAMAOBKDM4EATM
SCHEMBL9001650 0.68 MAOA (0.63) HSD17B2KDM1AMAOAMAOBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK HSD17B2 138/4885KDM1A 2738/4885MAOA 654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback